Apolipoprotein F-Mangel
Bei Apolipoprotein F-Mangel fehlt das Protein im Plasma. Wesentliche Veränderungen des Lipidstatus werden nicht gesehen und ob eine Auswirkung auf die Progression von Gefäßerkrankungen besteht kann nicht beantwortet werden.
Gliederung
Apolipoprotein-Mangel
|
|||||
|
APOA5
| ||||
|
|
APOB
| ||||
|
|
APOC1
| ||||
|
|
APOC2
| ||||
|
|
APOC3
| ||||
|
|
APOE
| ||||
|
|
APOL1
| ||||
|
|
APOM
| ||||
|
|
Apolipoprotein A1-Mangel
| ||||
|
|
Apolipoprotein A2-Mangel
| ||||
|
Apolipoprotein F-Mangel
| ||||
|
|
APOF
| |||
|
|
Apolipoprotein H-Mangel
| ||||
|
|
CLU
| ||||
|
|
|
|
|
|
Referenzen:
| 1. |
Lagor WR et al. (2009) Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo. [^] |
| 2. |
Olofsson SO et al. (1978) Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. [^] |
| 3. |
Lagor WR et al. (2012) The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice. [^] |
| 4. |
Koren E et al. (1982) Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma. [^] |
| 5. |
Day JR et al. (1994) Purification and molecular cloning of human apolipoprotein F. [^] |
| 6. |
Wang X et al. (1999) Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F. [^] |
